KPMA Chairman Make Suggestions to Government’s R&D Investment Policy
Published: 2004-12-21 07:00:00
Updated: 2004-12-21 07:00:00
In his recent contributing article to the JoongAng Daily, Chairman Kim Jung-soo of the Korea Pharmaceutical Manufacturers Association (KPMA) stated the importance of promoting an efficient R&D investment by the government to foster the development of new medicines.
Chairman Kim Jung-soo mentio...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
